Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENOATE: 443 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
443
Total FAERS Reports
40 (9.0%)
Deaths Reported
231
Hospitalizations
443
As Primary/Secondary Suspect
20
Life-Threatening
2
Disabilities

Active Ingredient: CANRENOATE POTASSIUM ·

First Report: 198611 · Latest Report: 20241201

What Are the Most Common CANRENOATE Side Effects?

#1 Most Reported
Hyperkalaemia
96 reports (21.7%)
#2 Most Reported
Acute kidney injury
63 reports (14.2%)
#3 Most Reported
Toxic epidermal necrolysis
58 reports (13.1%)

All CANRENOATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hyperkalaemia 96 21.7% 7 63
Acute kidney injury 63 14.2% 3 39
Toxic epidermal necrolysis 58 13.1% 18 8
Hyponatraemia 52 11.7% 0 38
Off label use 45 10.2% 1 12
Dehydration 39 8.8% 6 29
Hypotension 39 8.8% 0 25
Drug hypersensitivity 37 8.4% 0 9
Dyspnoea 36 8.1% 0 27
Asthenia 33 7.5% 0 23
Bradycardia 26 5.9% 1 9
Product use in unapproved indication 24 5.4% 0 2
Metabolic acidosis 23 5.2% 0 20
Fall 22 5.0% 4 21
Headache 22 5.0% 0 10
Sopor 22 5.0% 0 22
Pyrexia 21 4.7% 10 12
Syncope 21 4.7% 0 9
Vomiting 21 4.7% 1 10
Loss of consciousness 20 4.5% 0 15

Who Reports CANRENOATE Side Effects? Age & Gender Data

Gender: 43.5% female, 56.5% male. Average age: 70.8 years. Most reports from: IT. View detailed demographics →

Is CANRENOATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 13 13 0
2005 1 1 1
2006 35 0 1
2007 1 0 0
2009 1 0 1
2010 15 0 5
2011 4 0 2
2012 11 0 8
2013 6 0 6
2014 9 1 6
2015 19 2 9
2016 26 0 11
2017 27 0 12
2018 48 4 27
2019 88 6 54
2020 34 0 30
2021 10 3 3
2022 18 1 6
2023 18 1 14
2024 4 1 4

View full timeline →

What Is CANRENOATE Used For?

IndicationReports
Product used for unknown indication 148
Hypertension 97
Cardiac failure 37
Ill-defined disorder 32
Agitation 12
Drug abuse 12
Hypokalaemia 8
Renal impairment 8
Oedema 7
Covid-19 5

CANRENOATE vs Alternatives: Which Is Safer?

CANRENOATE vs CANRENOIC ACID CANRENOATE vs CANRENONE CANRENOATE vs CANTHARIDIN CANRENOATE vs CAPECITABINE CANRENOATE vs CAPIVASERTIB CANRENOATE vs CAPLACIZUMAB CANRENOATE vs CAPLACIZUMAB-YHDP CANRENOATE vs CAPMATINIB CANRENOATE vs CAPREOMYCIN CANRENOATE vs CAPSAICIN

Official FDA Label for CANRENOATE

Official prescribing information from the FDA-approved drug label.